Abstract

BackgroundActinoplanes sp. SE50/110 is the natural producer of the diabetes mellitus drug acarbose, which is highly produced during the growth phase and ceases during the stationary phase. In previous works, the growth-dependency of acarbose formation was assumed to be caused by a decreasing transcription of the acarbose biosynthesis genes during transition and stationary growth phase.ResultsIn this study, transcriptomic data using RNA-seq and state-of-the-art proteomic data from seven time points of controlled bioreactor cultivations were used to analyze expression dynamics during growth of Actinoplanes sp. SE50/110. A hierarchical cluster analysis revealed co-regulated genes, which display similar transcription dynamics over the cultivation time. Aside from an expected metabolic switch from primary to secondary metabolism during transition phase, we observed a continuously decreasing transcript abundance of all acarbose biosynthetic genes from the early growth phase until stationary phase, with the strongest decrease for the monocistronically transcribed genes acbA, acbB, acbD and acbE. Our data confirm a similar trend for acb gene transcription and acarbose formation rate.Surprisingly, the proteome dynamics does not follow the respective transcription for all acb genes. This suggests different protein stabilities or post-transcriptional regulation of the Acb proteins, which in turn could indicate bottlenecks in the acarbose biosynthesis. Furthermore, several genes are co-expressed with the acb gene cluster over the course of the cultivation, including eleven transcriptional regulators (e.g. ACSP50_0424), two sigma factors (ACSP50_0644, ACSP50_6006) and further genes, which have not previously been in focus of acarbose research in Actinoplanes sp. SE50/110.ConclusionIn conclusion, we have demonstrated, that a genome wide transcriptome and proteome analysis in a high temporal resolution is well suited to study the acarbose biosynthesis and the transcriptional and post-transcriptional regulation thereof.

Highlights

  • SE50/110 steadily decreases during the growth phase and almost ceases in stationary phase In this study, the changes of acarbose production during the growth of Actinoplanes sp

  • SE50/110 was cultivated in maltose minimal medium in three biological replicates

  • Samples were taken at regular intervals to monitor the course of growth and acarbose formation

Read more

Summary

Introduction

SE50/110 is the natural producer of the diabetes mellitus drug acarbose, which is highly produced during the growth phase and ceases during the stationary phase. SE50/110 is a Gram-positive, aerobic bacterium belonging to the genus of Actinoplanes, within the family Micromonosporaceae [1, 2]. Members of the genus Actinoplanes can form sporangia, that contain motile spores, and typically grow in branched hyphae [1, 3]. Several species are known for their potential to produce a variety of secondary metabolites, like antibiotics [4, 5]. Due to its inhibitory effect, acarbose is used for the treatment of diabetes mellitus. The postprandial blood and serum sugar glucose is reduced, which is a risk factor for developing secondary complications, like cardiovascular diseases, diabetical retinopathies and diabetic food syndrome [14]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call